| Magnetic resonance imaging–guided vs computed tomography–guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial AU Kishan, TM Ma, JM Lamb, M Casado, H Wilhalme, DA Low, K Sheng, ... JAMA oncology 9 (3), 365-373, 2023 | 300 | 2023 |
| Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis AU Kishan, Y Sun, H Hartman, TM Pisansky, M Bolla, A Neven, A Steigler, ... The lancet oncology 23 (2), 304-316, 2022 | 181 | 2022 |
| Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion TM Ma, S Abazyan, B Abazyan, J Nomura, C Yang, S Seshadri, A Sawa, ... Molecular Psychiatry, 2012 | 171 | 2012 |
| D-serine in glia and neurons derives from 3-phosphoglycerate dehydrogenase JT Ehmsen, TM Ma, H Sason, D Rosenberg, T Ogo, S Furuya, SH Snyder, ... Journal of Neuroscience 33 (30), 12464-12469, 2013 | 132 | 2013 |
| MR-guided radiotherapy for prostate cancer BR Tocco, AU Kishan, TM Ma, LGW Kerkmeijer, AC Tree Frontiers in Oncology 10, 616291, 2020 | 95 | 2020 |
| The role of multiparametric magnetic resonance imaging/ultrasound fusion biopsy in active surveillance TM Ma, JJ Tosoian, EM Schaeffer, P Landis, S Wolf, KJ Macura, JI Epstein, ... European urology 71 (2), 174-180, 2017 | 94 | 2017 |
| A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation TM Ma, J Grimm, R McIntyre, H Anderson-Keightly, LR Kleinberg, ... Radiotherapy and Oncology 125 (2), 234-240, 2017 | 91 | 2017 |
| Local failure events in prostate cancer treated with radiotherapy: a pooled analysis of 18 randomized trials from the meta-analysis of randomized trials in cancer of the … TM Ma, FI Chu, H Sandler, FY Feng, JA Efstathiou, CU Jones, ... European urology 82 (5), 487-498, 2022 | 59 | 2022 |
| Inositol hexakisphosphate kinase-3 regulates the morphology and synapse formation of cerebellar purkinje cells via spectrin/adducin C Fu, J Xu, RJ Li, JA Crawford, AB Khan, TM Ma, JY Cha, AM Snowman, ... Journal of Neuroscience 35 (31), 11056-11067, 2015 | 58 | 2015 |
| Quality-of-life outcomes and toxicity profile among patients with localized prostate cancer after radical prostatectomy treated with stereotactic body radiation: the SCIMITAR … TM Ma, LK Ballas, H Wilhalme, A Sachdeva, N Chong, S Sharma, T Yang, ... International Journal of Radiation Oncology* Biology* Physics 115 (1), 142-152, 2023 | 57 | 2023 |
| Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial TM Ma, JM Lamb, M Casado, X Wang, TV Basehart, Y Yang, D Low, ... BMC cancer 21 (1), 538, 2021 | 50 | 2021 |
| Serine racemase regulated by binding to stargazin and PSD-95 TM Ma, BD Paul, C Fu, S Hu, H Zhu, S Blackshaw, H Wolosker, ... Journal of Biological Chemistry 289 (43), 29631-29641, 2014 | 50 | 2014 |
| Interplay between duration of androgen deprivation therapy and external beam radiotherapy with or without a brachytherapy boost for optimal treatment of high-risk prostate … AU Kishan, A Steigler, JW Denham, A Zapatero, A Guerrero, D Joseph, ... JAMA oncology 8 (3), e216871-e216871, 2022 | 47 | 2022 |
| Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided … TM Ma, J Neylon, M Casado, S Sharma, K Sheng, D Low, Y Yang, ... Radiotherapy and Oncology 167, 203-210, 2022 | 46 | 2022 |
| Sequencing of androgen-deprivation therapy of short duration with radiotherapy for nonmetastatic prostate cancer (SANDSTORM): a pooled analysis of 12 randomized trials TM Ma, Y Sun, S Malone, M Roach III, D Dearnaley, TM Pisansky, ... Journal of Clinical Oncology 41 (4), 881-892, 2023 | 43 | 2023 |
| High-dose radiotherapy or androgen deprivation therapy (HEAT) as treatment intensification for localized prostate cancer: an individual patient–data network meta-analysis from … AU Kishan, X Wang, Y Sun, T Romero, JM Michalski, TM Ma, FY Feng, ... European Urology 82 (1), 106-114, 2022 | 43 | 2022 |
| Understanding the underutilization of cervical brachytherapy for locally advanced cervical cancer TM Ma, MM Harkenrider, CM Yashar, AN Viswanathan, JS Mayadev Brachytherapy 18 (3), 361-369, 2019 | 37 | 2019 |
| Performance of a prostate-specific membrane antigen positron emission tomography/computed tomography–derived risk-stratification tool for high-risk and very high-risk prostate … M Xiang, TM Ma, R Savjani, EL Pollom, RJ Karnes, T Grogan, JK Wong, ... JAMA network open 4 (12), e2138550-e2138550, 2021 | 35 | 2021 |
| Magnetic resonance imaging-guided versus computed tomography-guided stereotactic body radiotherapy for prostate cancer (MIRAGE): Interim analysis of a phase III randomized trial. AU Kishan, J Lamb, M Casado, X Wang, TM Ma, D Low, K Sheng, Y Yang, ... Journal of Clinical Oncology 40 (6_suppl), 255-255, 2022 | 31 | 2022 |
| Biochemical recurrence surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate S Roy, T Romero, JM Michalski, FY Feng, JA Efstathiou, CAF Lawton, ... Journal of Clinical Oncology 41 (32), 5005-5014, 2023 | 28 | 2023 |
Herman WoloskerTechnion-Israel Institute of TechnologyVerified email at tx.technion.ac.il
